The prevalence of voiding difficulty after TVT, its impact on quality of life, and related risk factors
Harry A.M. Vervest(Elisabeth-TweeSteden Ziekenhuis), Steven E. Schraffordt Koops(Meander Medisch Centrum), Tanya M. Bisseling(Radboud University Nijmegen), A. Peter M. Heintz(University Medical Center Utrecht)
Cited by 33
Related Papers
Hereditary diffuse gastric cancer: updated clinical guidelines with an emphasis on germline <i>CDH1</i> mutation carriers
|Journal of Medical Genetics|2015|567
Hereditary diffuse gastric cancer: updated clinical practice guidelines
|The Lancet Oncology|2020|493
Cancer Surveillance Guideline for individuals with PTEN hamartoma tumour syndrome
|European Journal of Human Genetics|2020|141